BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $1,124,755 (100.0% shares, 0.0% debt)

Holdings (7)

MNST MONSTER BEVERAGE CORP NEW 40.0%

Value ($000) $450,140 Shares 8,501,236 Est. Cost $36.99 Unrealized +53.6%

STAA STAAR SURGICAL CO 33.1%

Value ($000) $372,245 Shares 9,264,427 Est. Cost $11.34 Unrealized +312.9%

AXON AXON ENTERPRISE INC 13.4%

Value ($000) $151,245 Shares 760,062 Est. Cost $27.50 Unrealized +615.3%

IWM ISHARES TR 8.9%

Value ($000) $100,035 Shares 566,000 Est. Cost $112.69 Unrealized —

LCTX LINEAGE CELL THERAPEUTICS INC 3.7%

Value ($000) $41,224 Shares 34,935,485 Est. Cost $1.04 Unrealized +30.2%

IMDX ONCOCYTE CORP 0.7%

Value ($000) $7,828 Shares 2,509,066 Est. Cost $3.72 Unrealized 0.0%

— AGEX THERAPEUTICS INC 0.2%

Value ($000) $2,038 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MNST	MONSTER BEVERAGE CORP NEW	8,501,236	$450,140	40.0%	$36.99	+53.6%	COM	61174X109
STAA	STAAR SURGICAL CO	9,264,427	$372,245	33.1%	$11.34	+312.9%	COM PAR $0.01	852312305
AXON	AXON ENTERPRISE INC	760,062	$151,245	13.4%	$27.50	+615.3%	COM	05464C101
IWM	ISHARES TR	566,000	$100,035	8.9%	$112.69	—	RUSSELL 2000 ETF	464287655
LCTX	LINEAGE CELL THERAPEUTICS INC	34,935,485	$41,224	3.7%	$1.04	+30.2%	COM	53566P109
IMDX	ONCOCYTE CORP	2,509,066	$7,828	0.7%	$3.72	0.0%	COM NEW	68235C206
—	AGEX THERAPEUTICS INC	2,997,156	$2,038	0.2%	$2.99	—	COM	00848H108